Fuat Oduncu

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

Salah‐Eddin Al‐Batran, Nils Homann, Claudia Pauligk et al. · The Lancet · 2019 · 2.4K citations

Surgical Oncology, Esophageal Cancer, Gastrointestinal Oncology +9

A recombinant trispecific single‐chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targeting

Markus Kügler, Christoph Stein, Christian Kellner et al. · British Journal of Haematology · 2010 · 128 citations · Full text

Hematological Malignancy, Malignant Blood Disorder, Immunology +14

The novel orally bioavailable inhibitor of phosphoinositol-3-kinase and mammalian target of rapamycin, NVP-BEZ235, inhibits growth and proliferation in multiple myeloma

Philipp Baumann, Sonja Mandl–Weber, Fuat Oduncu et al. · Experimental Cell Research · 2008 · 122 citations

Hematological Malignancy, Mammalian Target, Medicine +8

Dihydroorotate dehydrogenase inhibitor A771726 (leflunomide) induces apoptosis and diminishes proliferation of multiple myeloma cells

Philipp Baumann, Sonja Mandl–Weber, Andreas Völkl et al. · Molecular Cancer Therapeutics · 2009 · 112 citations

Hematologic Malignancies in Pregnancy: Management Guidelines From an International Consensus Meeting

Michael Lishner, Irit Avivi, Jane F. Apperley et al. · Journal of Clinical Oncology · 2015 · 104 citations · Full text

Management Guidelines, Pregnancy Disorders, Reproductive Health +20